Melissa O'Connor, PhD, MBA, RN, FGSA, FAAN, endowed professor in Community and Home Health Nursing, M. Louise Fitzpatrick School of Nursing, Villanova University, and director, Gerontology Interest Group, addressed gaps in research for home health care and progress toward the development of a discharge decision support tool for clinicians.
More funding and research leveraging real-world data is required to create a standardized discharge decision support tool in home health, said Melissa O'Connor, PhD, MBA, RN, FGSA, FAAN, endowed professor in Community and Home Health Nursing, M. Louise Fitzpatrick School of Nursing, Villanova University, and director, Gerontology Interest Group.
Transcript
Why is there no national standard or tool to determine when older adults are ready to be without skilled home support?
So, I'm working very hard on that. There is limited research in home health, due primarily to funding. And rigorous research takes time, as well as funding. Developing decision support in home health that is based on the evidence, and that is using real-world data is what I'm currently working on.
It's funded by a [University of California, Davis] Betty Irene Moore [School Of Nursing] fellowship for nurse leaders and innovators. But without decision support, the home health team is relying on individual clinician judgment to determine when patients are ready or when payers say they are ready rather than objective, available in real time data that will lead to the best patient outcomes.
We need to be able to identify patients who are ready for discharge vs those who are not because we don't want to just continue on with home health for everyone—we can't afford that and that doesn't make sense. But to answer your question, it's really because these things take time, they take funding, and we're working on it. So, hopefully within the next year or two, you will start to see a discharge decision support tool emerge that hopefully will be implemented nationally and embedded in the electronic health record.
NGS-Based Test Accurately Detects Post–Allo-HSCT Relapse in AML, MDS
February 21st 2025The next-generation sequencing (NGS)–based AlloHeme test accurately predicted relapse following allogeneic hematopoietic stem cell transplantation (allo-HSCT) in acute myeloid leukemia (AML) and myelodysplastic syndromes (MDS).
Read More
Insurance Payer Is Associated With Length of Stay After Traumatic Brain Injury
February 21st 2025Among hospitalized patients with traumatic brain injury, Medicaid fee-for-service was associated with longer hospital stays than private insurance and Medicaid managed care organizations.
Read More
Politics vs Science: The Future of US Public Health
February 4th 2025On this episode of Managed Care Cast, we speak with Perry N. Halkitis, PhD, MS, MPH, dean of the Rutgers School of Public Health, on the public health implications of the US withdrawal from the World Health Organization and the role of public health leaders in advocating for science and health.
Listen
NSCLC Advancements Offer Hope, but Disparities Persist
February 20th 2025Ioana Bonta, MD, Georgia Cancer Specialists, discusses the evolving state of non-small cell lung cancer (NSCLC) treatments, their impact on patient outcomes, and the need to address ongoing disparities in these populations.
Read More
Abortion in 2025: Access, Fertility, and Infant Mortality Updates
February 20th 2025While Republican state-led efforts aim to increase restrictions to abortion care and access to mifepristone and misoprostol in 2025, JAMA authors join the conversation with their published research and commentary.
Read More